VOYA Investment Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

VOYA Investment Management’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-700	Closed	-$18.8K	–	3032
2023 Q1	$18.8K	Buy	700 +163	+30%	+$7.58K	﹤0.01%	2873
2022 Q4	$19K	Hold	537	–	–	﹤0.01%	2915
2022 Q3	$121K	Hold	537	–	–	﹤0.01%	2736
2022 Q2	$102K	Buy	537 +91	+20%	+$18.3K	﹤0.01%	2613
2022 Q1	$111K	Hold	446	–	–	﹤0.01%	2500
2021 Q4	$69K	Sell	446 -17	-4%	-$3.29K	﹤0.01%	2719
2021 Q3	$93K	Hold	463	–	–	﹤0.01%	2749
2021 Q2	$118K	Hold	463	–	–	﹤0.01%	2742
2021 Q1	$123K	Sell	463 -355	-43%	-$112K	﹤0.01%	2640
2020 Q4	$302K	Buy	818 +206	+34%	+$59.1K	﹤0.01%	2192
2020 Q3	$149K	Buy	+612	New	+$190K	﹤0.01%	2248
2020 Q2	–	Sell	-377	Closed	-$77K	–	2647
2020 Q1	$77K	Hold	377	–	–	﹤0.01%	2407
2019 Q4	$168K	Buy	+377	New	+$134K	﹤0.01%	2429

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

VOYA Investment Management's EIGR Position: Q2 2023 in Review

VOYA Investment Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2023, closing a stake of 700 shares — an estimated $18.8K sold.

VOYA Investment Management first reported a position in EIGR in Q4 2019 and held it in 13 quarters. The position peaked at $302K in Q4 2020. 66 funds tracked by Wall St. Rank hold EIGR as of Q2 2023.

VOYA Investment Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
VOYA Investment Management sold 700 Eiger BioPharmaceuticals, Inc. shares in Q2 2023, an estimated $18.8K.
VOYA Investment Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2019 and held it in 13 quarters.
VOYA Investment Management's Eiger BioPharmaceuticals, Inc. position peaked at $302K in Q4 2020.
66 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2023.

Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.